RF Biosensor Platform
Broad-spectrum diagnostic for biomarkers and infectious agents
Pre-clinicalActive
Key Facts
Indication
Broad-spectrum diagnostic for biomarkers and infectious agents
Phase
Pre-clinical
Status
Active
About Aviana Molecular Technologies
Aviana Molecular Technologies is a private, pre-revenue diagnostics company founded in 2017 and headquartered in Orlando, Florida. The company is developing a portable, real-time diagnostic platform that uses piezoelectric radio frequency (RF) sensors in disposable cartridges, interfacing with a smartphone or tablet via Bluetooth. Led by a founder with deep pharmaceutical and FDA experience, Aviana targets the unmet need for rapid, sensitive, and quantitative point-of-care testing for infectious diseases and other biomarkers. Its core value proposition is enabling lab-quality results in field settings within minutes.
View full company profile